Olio Labs
PrivateLast Round
Seed
Mar 19, 2025
Total Funding Raised
$8.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Olio Labs operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in March 2025.
Olio Labs is a biotechnology company that develops a therapeutic design platform utilizing artificial intelligence to create combination therapeutics for complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Olio Labs Comparables
Compare Olio Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Algen Biotechnologies | 80% | |
| Eigen Therapeutics | 78% | |
| Superluminal Medicines | 77% |
For institutional investors. Book with your work email.
Olio Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 19, 2025 | ||||
| Seed | Jul 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Olio Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Fund | Seed |
| Boom Capital | Seed |
| ZAKA VC | Seed |
| Y Combinator | Seed |
| Unpopular Ventures | Seed |
| Olive Capital | Seed |
| Overwater Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Grew 44% QoQ from 9 to 13 employees.
- Mar 19, 2025
$5M Series A round completed.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesAug 5, 2026
Olio Labs, Inc. launches an AI-driven in vivo platform designed to predict clinical trial outcomes.
For institutional investors. Book with your work email.
Olio Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Olio Labs's valuation, stock price, and market status.
Is Olio Labs a public or private company?
Olio Labs is a private company.
What is the current stock price of Olio Labs?
Olio Labs is a private company, so its shares have no public market price. Caplight tracks Olio Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Olio Labs worth (valuation)?
Valuation information for Olio Labs is not publicly available.
Can I buy Olio Labs stock?
Olio Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Olio Labs's last funding round?
Olio Labs's most recent funding round was Seed on March 19, 2025.
Who are the main investors in Olio Labs?
Key investors in Olio Labs include Boom Capital, Y Combinator, Overwater Ventures.
Will Olio Labs IPO soon?
No public IPO plans have been announced for Olio Labs.
How can I track Olio Labs secondary market activity?
Caplight tracks bids, offers, and trades in Olio Labs's shares on secondary markets.